Bimeo has been successfully employed in rehabilitation of Multiple Sclerosis (MS) patients. Results of the first Bimeo MS study were presented on the 20th of June 2019 at the annual RIMS conference by Ms. Jelka Janša, OT.
The study involved a group of 12 MS patients. Each patient concluded 10 therapy sessions with Bimeo. Therapy session duration was 20 min.
Researchers observed improvements in COPM, FMA and Box&Blocks clinical scales. That’s amazing. More and more studies are showing effectiveness of Bimeo therapy in everyday clinical practice.